Furthermore, besides hypercortisolism per se, alterations in mineralocorticoid activity might explain changes in cardiac structure and function observed in patients with Cushing’s syndrome (15, 16), given the well-known adverse effects of angiotensin II and aldosterone on the heart (7, 17). The gene discussed is AGT; the disease is Cushing syndrome.